COVID-19/SARS-COV-2 / LETTER TO THE EDITOR
Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection
| 1 | University Hospital Nuestra Señora de Candelaria, Spain |
| 2 | bFoundation of the Canary Islands Health Research Institute (FIISC), Spain |
CORRESPONDING AUTHOR
José María Hernández Pérez
University Hospital Nuestra Señora de Candelaria, Carretera General del Rosario, 145, 38010, Santa Cruz de Tenerife, Spain
University Hospital Nuestra Señora de Candelaria, Carretera General del Rosario, 145, 38010, Santa Cruz de Tenerife, Spain
Submission date: 2021-01-26
Final revision date: 2021-04-28
Acceptance date: 2021-05-11
Publication date: 2021-05-22
Arch Med Sci 2021;17(4):1134–1136
TOPICS
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.